Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX

Morgan Stanley reported a 6.30% stake in Syndax Pharmaceuticals, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 5, 2025

Morgan Stanley reported a 6.30% stake in Syndax Pharmaceuticals, Inc., 5,362,169 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G).

Stake
6.30%
Shares
5,362,169
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Morgan Stanley6.30%5,362,169
Morgan Stanley & Co. LLC5.90%5,055,451

Source

View original at SEC

Related